
Finland - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Finland: Medicaments Containing Insulin Market 2023
Medicaments Containing Insulin Market Size in Finland
In 2021, the Finnish medicaments containing insulin market decreased by 0% to less than $X, falling for the second consecutive year after three years of decline. Over the period under review, consumption saw a sharp decline. The growth pace was the most rapid in 2013 when the market value decreased by -68.7%. Medicaments containing insulin consumption peaked at $X in 2016; however, from 2017 to 2021, consumption failed to regain momentum.
Medicaments Containing Insulin Exports
Exports from Finland
In 2019, overseas shipments of medicaments containing insulin but not antibiotics decreased by -50% to X kg for the first time since 2011, thus ending a seven-year rising trend. In general, exports recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2018 when exports increased by 100%. As a result, the exports attained the peak of X kg, and then contracted dramatically in the following year.
In value terms, medicaments containing insulin exports fell sharply to $X in 2019. Over the period under review, exports, however, posted a significant increase. The most prominent rate of growth was recorded in 2018 when exports increased by 251% against the previous year. As a result, the exports reached the peak of $X, and then shrank rapidly in the following year.
Exports by Country
From 2013 to 2021, the average annual rate of growth in terms of volume to No country was relatively modest.
From 2013 to 2021, the average annual rate of growth in terms of value to No country was relatively modest.
Export Prices by Country
The average medicaments containing insulin export price stood at $X per ton in 2019, picking up by 24% against the previous year. Over the last one years, it increased at an average annual rate of +23.9%. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.
As there is only one major export destination, the average price level is determined by prices for the Netherlands.
From 2018 to 2019, the rate of growth in terms of prices for the Netherlands amounted to 0.0% per year.
Medicaments Containing Insulin Imports
Imports into Finland
In 2019, after two years of decline, there was decline in overseas purchases of medicaments containing insulin but not antibiotics, when their volume decreased by 0% to X kg. In general, imports recorded a abrupt downturn. The pace of growth was the most pronounced in 2016 with an increase of 700%. As a result, imports reached the peak of X kg. From 2017 to 2019, the growth of imports failed to regain momentum.
In value terms, medicaments containing insulin imports dropped to $X in 2019. Overall, imports continue to indicate pronounced growth. The pace of growth appeared the most rapid in 2016 with an increase of 426%. As a result, imports attained the peak of $X. From 2017 to 2019, the growth of imports remained at a lower figure.
Imports by Country
In 2019, the Netherlands (X kg) was the main supplier of medicaments containing insulin to Finland, accounting for a approx. 100% share of total imports.
From 2012 to 2019, the average annual growth rate of volume from the Netherlands was relatively modest.
In value terms, the Netherlands ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Finland, comprising 96% of total imports. The second position in the ranking was held by Austria ($X), with a 4.5% share of total imports.
From 2012 to 2019, the average annual rate of growth in terms of value from the Netherlands stood at +38.0%.
Import Prices by Country
In 2019, the average medicaments containing insulin import price amounted to $X per ton, which is down by -9.2% against the previous year. In general, the import price, however, continues to indicate significant growth. The most prominent rate of growth was recorded in 2014 an increase of 80%. Over the period under review, average import prices hit record highs at $X per ton in 2015; however, from 2016 to 2019, import prices failed to regain momentum.
There were significant differences in the average prices amongst the major supplying countries. In 2019, amid the top importers, the country with the highest price was Austria ($X per ton), while the price for the Netherlands totaled $X per ton.
From 2012 to 2019, the most notable rate of growth in terms of prices was attained by Sweden (+1,790.9%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
Base Year | Historical Period | Forecast Period | Units |
---|---|---|---|
2022 | 2012-2022 | 2023-2030 | US$, Tons |
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the medicaments containing insulin market in Finland. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Making Data-Driven Decisions to Grow Your Business
A Quick Overview of Market Performance
Understanding the Current State of The Market and Its Prospects
Finding New Products to Diversify Your Business
Choosing the Best Countries to Establish Your Sustainable Supply Chain
Choosing the Best Countries to Boost Your Exports
The Latest Trends and Insights into The Industry
The Largest Import Supplying Countries
The Largest Destinations for Exports
The Largest Producers on The Market and Their Profiles
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 22nd, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 8th, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, January 25th, 2022 @ 04:00 pm ET